SOMAÍ Brings Iridescent Med — One of Thailand's Leading Medical Cannabis Brands —to the UK

Female-founded, indoor-grown flower brand enters Europe as SOMAÍ expands its international portfolio of pharmaceutical-grade cannabis medicines

LISBON, PORTUGAL, September 22, 2026 /EINPresswire.com/ -- SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, today announced the launch of Iridescent Med in the United Kingdom, marking the brand's first entry into the European medical cannabis market.

Founded and led by Ms. Siratcha "Min" Patcharasopachai, Iridescent Med is one of Thailand's most recognized and trusted cannabis brands, built on deep cultivation expertise developed in Thailand. The brand's indoor-grow model is designed to produce cannabis with the consistency, purity, and traceability that patients and prescribing physicians expect from a medicine — not a commodity.

"Patients don't just deserve access to cannabis. They deserve access to cannabis they can trust — grown the same way every time, tested the same way every time, with nothing left to chance," said Ms. Siratcha "Min" Patcharasopachai, Founder and CEO of Iridescent Med. "Bringing Iridescent Med to the UK with SOMAÍ is the next chapter of something we built from the ground up in Thailand, and I'm proud to be doing it as a woman leading in an industry that hasn't always made room for us."

The launch adds a female-led, Asian-cultivated brand to SOMAÍ's growing European portfolio at a moment when both markets are expanding quickly. Iridescent Med enters both simultaneously, distributed through SOMAÍ's existing pharmaceutical supply chain and pharmacy networks.

"Min built Iridescent Med into one of the most trusted names in Thai medical cannabis through an incredible attention to detail that permeates through the presentation of the flower to the image of the brand — clean-room cultivation, real certification, real consistency," said Michael Sassano, Founder and Interim CEO. "With sheer discipline in the grow and in the field, Somai is proud to be a valuable part of Min’s choices and her leadership, to bring her product and vision to European patients."

Iridescent Med is distributed to pharmacies in the UK by Hologram, an independent wholesaler.


About Iridescent Med

Iridescent Med is a female-founded medical cannabis cultivator in Thailand, producing premium-quality indoor-grown flower under GACP-certified cultivation standards. Their high-technology facility combines precision environmental control, ISO Class 8 cleanroom standards, advanced genetics developed in-house, and rigorous quality systems. Each batch is cultivated for consistency, traceability, product integrity, and rich terpene expression, delivering premium medical cannabis for patients and healthcare professionals worldwide.

About SOMAÍ

SOMAÍ is a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract and flower portfolio. SOMAÍ owns a state-of-the-art manufacturing facility, SOMAÍ Pharmaceuticals, and indoor cultivation NovaSoma in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of the few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.

About Hologram

Hologram^® is an independent Home Office licensed wholesaler of unlicensed medicines in the UK, specialising in medicinal cannabis. Hologram redefines UK medicinal cannabis distribution by focusing entirely on providing reliable supply of quality products. It works with specialist doctors, clinics, and pharmacies, to help them deliver the best possible experience for patients, and those that care for them. Hologram is independent - it does not operate its own pharmacy or clinic, neither does it cultivate or manufacture its own products. This ensures Hologram is invested in the success of its suppliers and customers.

Nataliia Garnina
SOMAÍ Pharmaceuticals LDA
+351 263 244 000
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X